{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:43:49Z","timestamp":1791859429588,"version":"4.3.4"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.2215\/cjn.11511114","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T21:42:51Z","timestamp":1429306971000},"page":"1079-1088","source":"Crossref","is-referenced-by-count":158,"title":["Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD"],"prefix":"10.2215","volume":"10","author":[{"given":"Hiddo J.","family":"Lambers Heerspink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20230601","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ndt\/gfn741","article-title":"Hermann Senator and albuminuria\u2014forgotten pioneering work in the 19th century","volume":"24","author":"Gansevoort","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R2-23-20230601","first-page":"343","article-title":"Renal pathology and proteinuria determine progression in untreated mild\/moderate chronic renal failure","volume":"67","author":"Williams","year":"1988","journal-title":"Q J Med"},{"key":"R4-23-20230601","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ki.2011.61","article-title":"Strengths and weaknesses of renal markers as risk factors and surrogate markers","volume":"79","author":"Johnson","year":"2011","journal-title":"Kidney Int"},{"key":"R5-23-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2014.10.014","article-title":"Microalbuminuria: A parameter that has changed diabetes care","volume":"107","author":"Parving","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"R6-23-20230601","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ki.1990.217","article-title":"Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?","volume":"38","author":"Remuzzi","year":"1990","journal-title":"Kidney Int"},{"key":"R7-23-20230601","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R8-23-20230601","first-page":"S60","article-title":"Proteinuria and tubulointerstitial injury","volume":"61","author":"Chen","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"R9-23-20230601","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1440-1797.2011.01525.x","article-title":"Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria","volume":"17","author":"Okada","year":"2012","journal-title":"Nephrology (Carlton"},{"key":"R10-23-20230601","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/sj.ki.5000141","article-title":"Renal albumin absorption in physiology and pathology","volume":"69","author":"Birn","year":"2006","journal-title":"Kidney Int"},{"key":"R11-23-20230601","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev.physiol.67.031103.154845","article-title":"Renal tubule albumin transport","volume":"67","author":"Gekle","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"R12-23-20230601","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1681\/ASN.2010050492","article-title":"Cubilin is essential for albumin reabsorption in the renal proximal tubule","volume":"21","author":"Amsellem","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R13-23-20230601","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MNH.0b013e3281eb9059","article-title":"Albumin transport and processing by the proximal tubule: Physiology and pathophysiology","volume":"16","author":"Pollock","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R14-23-20230601","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI8862","article-title":"Cubilin is an albumin binding protein important for renal tubular albumin reabsorption","volume":"105","author":"Birn","year":"2000","journal-title":"J Clin Invest"},{"key":"R15-23-20230601","doi-asserted-by":"crossref","first-page":"F562","DOI":"10.1152\/ajprenal.2001.280.4.F562","article-title":"Megalin and cubilin: Synergistic endocytic receptors in renal proximal tubule","volume":"280","author":"Christensen","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-23-20230601","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ndt\/gfs462","article-title":"Renal phenotypic investigations of megalin-deficient patients: Novel insights into tubular proteinuria and albumin filtration","volume":"28","author":"Storm","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R17-23-20230601","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1681\/ASN.2007111233","article-title":"Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides","volume":"20","author":"Macconi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R18-23-20230601","first-page":"1179","article-title":"Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway","volume":"13","author":"Morigi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R19-23-20230601","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1681\/ASN.V1071487","article-title":"Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: Implications for the pathophysiology of proteinuric states","volume":"10","author":"Dixon","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R20-23-20230601","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000066278","article-title":"Albumin induces NF-kappaB expression in human proximal tubule-derived cells (IHKE-1)","volume":"12","author":"Drumm","year":"2002","journal-title":"Cell Physiol Biochem"},{"key":"R21-23-20230601","doi-asserted-by":"crossref","first-page":"F748","DOI":"10.1152\/ajprenal.00442.2002","article-title":"Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells","volume":"285","author":"Lee","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"R22-23-20230601","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1681\/ASN.V8101537","article-title":"Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein","volume":"8","author":"Wang","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R23-23-20230601","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1046\/j.1523-1755.1998.00905.x","article-title":"Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation","volume":"53","author":"Zoja","year":"1998","journal-title":"Kidney Int"},{"key":"R24-23-20230601","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5414\/CNP58337","article-title":"Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria","volume":"58","author":"Vlachojannis","year":"2002","journal-title":"Clin Nephrol"},{"key":"R25-23-20230601","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0272-6386(95)90058-6","article-title":"Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins","volume":"26","author":"Zoja","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R26-23-20230601","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000098432","article-title":"Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells","volume":"27","author":"Whaley-Connell","year":"2007","journal-title":"Am J Nephrol"},{"key":"R27-23-20230601","doi-asserted-by":"crossref","first-page":"F1464","DOI":"10.1152\/ajprenal.00069.2006","article-title":"The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells","volume":"292","author":"Diwakar","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R28-23-20230601","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/ndt\/17.12.2145","article-title":"Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria","volume":"17","author":"Goumenos","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R29-23-20230601","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000075347","article-title":"Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells","volume":"24","author":"Stephan","year":"2004","journal-title":"Am J Nephrol"},{"key":"R31-23-20230601","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ki.2013.490","article-title":"Microalbuminuria: Target for renoprotective therapy PRO","volume":"86","author":"Roscioni","year":"2014","journal-title":"Kidney Int"},{"key":"R32-23-20230601","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2008060655","article-title":"Screening for albuminuria identifies individuals at increased renal risk","volume":"20","author":"van der Velde","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R33-23-20230601","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"R34-23-20230601","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/ndt\/gfu255","article-title":"A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R35-23-20230601","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1681\/ASN.2008070730","article-title":"Combining GFR and albuminuria to classify CKD improves prediction of ESRD","volume":"20","author":"Hallan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R36-23-20230601","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc07-0140","article-title":"Normoalbuminuric renal-insufficient diabetic patients: A lower-risk group","volume":"30","author":"Rigalleau","year":"2007","journal-title":"Diabetes Care"},{"key":"R38-23-20230601","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"R40-23-20230601","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000090222","article-title":"Sodium intake modifies the negative prognostic value of renal damage prior to treatment with ACE inhibitors on proteinuria induced by adriamycin","volume":"103","author":"Kramer","year":"2006","journal-title":"Nephron Physiol"},{"key":"R41-23-20230601","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"key":"R42-23-20230601","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1681\/ASN.2011040430","article-title":"Sodium intake, ACE inhibition, and progression to ESRD","volume":"23","author":"Vegter","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R43-23-20230601","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.ajkd.2014.02.020","article-title":"Early change in proteinuria as a surrogate end point for kidney disease progression: An individual patient meta-analysis","volume":"64","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R45-23-20230601","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2006121372","article-title":"Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A randomized controlled study of benazepril and losartan in chronic renal insufficiency","volume":"18","author":"Hou","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R46-23-20230601","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1681\/ASN.2014010012","article-title":"Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial","volume":"26","author":"Navarro-Gonz\u00e1lez","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R47-23-20230601","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial","volume":"47","author":"Group","year":"1995","journal-title":"Kidney Int"},{"key":"R48-23-20230601","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"de Boer","year":"2011","journal-title":"N Engl J Med"},{"key":"R49-23-20230601","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney Int"},{"key":"R50-23-20230601","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"R51-23-20230601","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1681\/ASN.V10112426","article-title":"Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group","volume":"10","author":"Levey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R53-23-20230601","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.2007090970","article-title":"Role of remission clinics in the longitudinal treatment of CKD","volume":"19","author":"Ruggenenti","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R54-23-20230601","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"R55-23-20230601","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/0091270010377502","article-title":"High level of proteinuria during treatment with renin-angiotensin inhibitors is a strong predictor of renal outcome in nondiabetic kidney disease","volume":"51","author":"Xie","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"R56-23-20230601","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"R57-23-20230601","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"R58-23-20230601","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"R59-23-20230601","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1523-1755.2001.0600031131.x","article-title":"Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease","volume":"60","author":"Jafar","year":"2001","journal-title":"Kidney Int"},{"key":"R60-23-20230601","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/CIRCULATIONAHA.110.964171","article-title":"Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: Results from the ONTARGET and TRANSCEND studies","volume":"123","author":"Tobe","year":"2011","journal-title":"Circulation"},{"key":"R61-23-20230601","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.111.018382","article-title":"ONTARGET still OFF-TARGET?","volume":"123","author":"Lambers Heerspink","year":"2011","journal-title":"Circulation"},{"key":"R62-23-20230601","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0962280207082719","article-title":"The Biomarker-Surrogacy Evaluation Schema: A review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints","volume":"17","author":"Lassere","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"R63-23-20230601","doi-asserted-by":"crossref","first-page":"d5160","DOI":"10.1136\/bmj.d5160","article-title":"Surrogates under scrutiny: Fallible correlations, fatal consequences","volume":"343","author":"Moynihan","year":"2011","journal-title":"BMJ"},{"key":"R64-23-20230601","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"Atkins","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R65-23-20230601","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American study of kidney disease and hypertension","volume":"165","author":"Lea","year":"2005","journal-title":"Arch Intern Med"},{"key":"R66-23-20230601","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1046\/j.1523-1755.2003.00033.x","article-title":"Retarding progression of chronic renal disease: The neglected issue of residual proteinuria","volume":"63","author":"Ruggenenti","year":"2003","journal-title":"Kidney Int"},{"key":"R67-23-20230601","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00125-012-2755-2","article-title":"A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus","volume":"56","author":"Roscioni","year":"2013","journal-title":"Diabetologia"},{"key":"R68-23-20230601","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease","volume":"22","author":"Schmieder","year":"2011","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201506000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:18Z","timestamp":1786369518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201506000-00023"}},"subtitle":["The Pro View"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11511114","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}